A detailed history of Tufton Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Tufton Capital Management holds 3,467 shares of LLY stock, worth $3.13 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
3,467
Previous 3,452 0.43%
Holding current value
$3.13 Million
Previous $2.69 Million 16.87%
% of portfolio
0.61%
Previous 0.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $10,873 - $13,635
15 Added 0.43%
3,467 $3.14 Million
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $660,895 - $884,184
1,116 Added 47.77%
3,452 $2.69 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $995,760 - $1.17 Million
1,896 Added 430.91%
2,336 $1.36 Million
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $154,325 - $206,351
440 New
440 $206,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $859B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tufton Capital Management Portfolio

Follow Tufton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.